Filing Details
- Accession Number:
- 0000950170-24-005900
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-01-19 19:32:12
- Reporting Period:
- 2024-01-18
- Accepted Time:
- 2024-01-19 19:32:12
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1880438 | An2 Therapeutics Inc. | ANTX | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1331852 | S Joseph Zakrzewski | C/O An2 Therapeutics, Inc. 1800 El Camino Real, Suite D Menlo Park CA 94027 | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2024-01-18 | 100,000 | $19.11 | 405,880 | No | 4 | S | Indirect | See footnote |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Indirect | See footnote |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 98,199 | Direct |
Footnotes
- These shares are held by Z3 Trust, for which the Reporting Person is a trustee.